series-a
Stage
1
Investors
About
Nevia Bio develops liquid-biopsy diagnostic tests analyzing vaginal fluid for earlier detection, monitoring, and treatment guidance of gynecological conditions, primarily targeting ovarian cancer.
Explore Nevia Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.